In those patients who achieved adjuvant chemotherapy, high expression level of p-FAK indicated both shorter OS (p < 0.01) and DFS (p < 0.01) for patients with stage II CRC (Figure 4B), and only shorter OS (p < 0.05) for stage III CRC patients (Figure 4C). Here, PTK2 is linked to colorectal carcinoma.